Abbott Labs' Judge Choice Leads To JPML Conflict Questions
By Greg Lamm ( July 28, 2022, 8:03 PM EDT) -- The Judicial Panel on Multidistrict Litigation raised no red flags Thursday about consolidating 18 lawsuits alleging that Abbott Laboratories' Similac infant formula caused a deadly illness in premature babies, but at a Seattle hearing the panel questioned whether Abbott's choice of judge has an appearance of conflict because he once represented the company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.